What Is New in Rome IV
Open accessThe DOI matches its Crossref record; 66 of the 68 references it cites were found in a registry or an index.
Abstract
Functional gastrointestinal disorders (FGIDs) are diagnosed and classified using the Rome criteria; the criteria may change over time as new scientific data emerge.The Rome IV was released in May 2016.The aim is to review the main changes in Rome IV.FGIDs are now called disorders of gut-brain interaction (DGBI).Rome IV has a multicultural rather than a Western-culture focus.There are new chapters including multicultural, age-gender-women's health, intestinal microenvironment, biopsychosocial, and centrally mediated disorders.New disorders have been included although not truly FGIDs, but fit the new definition of DGBI including opioidinduced gastrointestinal hyperalgesia, opioid-induced constipation, and cannabinoid hyperemesis.Also, new FGIDs based on available evidence including reflux hypersensitivity and centrally mediated abdominal pain syndrome.Using a normative survey to determine the frequency of normal bowel symptoms in the general population changes in the time frame for diagnosis were introduced.For irritable bowel syndrome (IBS) only pain is required and discomfort was eliminated because it is non-specific, having different meanings in different languages.Pain is now related to bowel movements rather than just improving with bowel movements (ie, can get worse with bowel movement).Functional bowel disorders (functional diarrhea, functional constipation, IBS with predominant diarrhea [IBS-D], IBS with predominant constipation [IBS-C], and IBS with mixed bowel habits) are considered to be on a continuum rather than as independent entities.Clinical applications such as diagnostic algorithms and the Multidimensional Clinical Profile have been updated.The new Rome IV iteration is evidence-based, multicultural oriented and with clinical applications.As new evidence become available, future updates are expected.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“the most recent guidelines suggest that IBS subgroups exist on a spectrum and not as distinct entities (69).”
From Alterations in Heart Rate Variability Associated With Irritable Bowel Syndrome or Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis (2021) · cites this paper as [69]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Longstreth, G. F., Thompson, W. G., Chey, W. D., Houghton, L. A., Mearin, F., & Spiller, R. C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.061 · Cited by 4,856
Lacy, B. E., Mearin, F., Chang, L., Chey, W. D., Lembo, A. J., Simren, M., & Spiller, R. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.031 · Cited by 2,866
Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV
Drossman, D. A. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.032 · Cited by 2,430
Self-citationFunctional Gastroduodenal Disorders
Tack, J., Talley, N. J., Camilleri, M., Holtmann, G., Hu, P., Malagelada, J.-R., & Stanghellini, V. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.059 · Cited by 2,418
Drossman, D. A., Li, Z., Andruzzi, E., Temple, R. D., Talley, N. J., Grant Thompson, W., Whitehead, W. E., Janssens, J., Funch-Jensen, P., Corazziari, E., et al. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01303162 · Cited by 2,198
Self-citationRome IV—Functional GI Disorders: Disorders of Gut-Brain Interaction
Drossman, D. A., & Hasler, W. L. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.03.035 · Cited by 1,928 · cited 2×
“Therefore, 28 years after the first Working Team on IBS, and 10 years after the last iteration of the Rome process (Rome III) were published, the Rome IV process and consequently the modified Rome IV classification and criteria have been published in a supplement of Gastroenterology as well as in a collection of books…”
MethodSelf-citationStanghellini, V., Chan, F. K. L., Hasler, W. L., Malagelada, J. R., Suzuki, H., Tack, J., & Talley, N. J. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.011 · Cited by 1,572
Barbara, G., Stanghellini, V., De Giorgio, R., Cremon, C., Cottrell, G. S., Santini, D., Pasquinelli, G., Morselli-Labate, A. M., Grady, E. F., Bunnett, N. W., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.055 · Cited by 1,475
Childhood Functional Gastrointestinal Disorders: Child/Adolescent
Hyams, J. S., Di Lorenzo, C., Saps, M., Shulman, R. J., Staiano, A., & van Tilburg, M. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.015 · Cited by 1,362
Opioids in chronic non-cancer pain: systematic review of efficacy and safety
Kalso, E., Edwards, J. E., Moore, A. R., & McQuay, H. J. (2004) · Pain · doi:10.1016/j.pain.2004.09.019 · Cited by 1,216 · cited 1×
“It has a prevalence of 41% in patients with chronic non-cancer pain, and up to 94% of patients taking opioids for cancer-related pain.(60) Initial treatment of OIC is similar to that of functional constipation including laxatives and lubiprostone has been approved by FDA for patients with OIC in patients with non-canc…”
BackgroundChildhood Functional Gastrointestinal Disorders: Neonate/Toddler
Benninga, M. A., Nurko, S., Faure, C., Hyman, P. E., St. James Roberts, I., & Schechter, N. L. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.016 · Cited by 1,099
Medication Augmentation after the Failure of SSRIs for Depression
Trivedi, M. H., Fava, M., Wisniewski, S. R., Thase, M. E., Quitkin, F., Warden, D., Ritz, L., Nierenberg, A. A., Lebowitz, B. D., Biggs, M. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052964 · Cited by 1,002 · cited 1×
“If necessary, an augumentation protocol, that is a combination of 2 or more treatments usually at lower dosages, that act at different receptor sites or areas of the brain may be used to enhance the therapeutic effect.(64) Narcotic bowel syndrome/opiate induced-gastrointestinal hyperalgesia is characterized by the par…”
BackgroundAltered rectal perception is a biological marker of patients with irritable bowel syndrome
Mertz, H., Naliboff, B., Munakata, J., Niazi, N., & Mayer, E. A. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90267-8 · Cited by 989
Disease and illness Distinctions between professional and popular ideas of sickness
Eisenberg, L. (1977) · Culture, Medicine and Psychiatry · doi:10.1007/bf00114808 · Cited by 800 · cited 1×
“Patients have symptoms or disease related beliefs that affect their concerns, anxieties, and expectations of the health care process known as explanatory models.(29) Although factors such as the cultural background, educational level, and sex can contribute to these explanatory models, we also recognize that local bio…”
BackgroundFunctional Anorectal Disorders
Bharucha, A. E., Wald, A., Enck, P., & Rao, S. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.064 · Cited by 775
The role of psychological and biological factors in postinfective gut dysfunction
Gwee, K.-A., Leong, Y.-L., Graham, C., McKendrick, M. W., Collins, S. M., Walters, S. J., Underwood, J. E., & Read, N. W. (1999) · Gut · doi:10.1136/gut.44.3.400 · Cited by 764
Development and Validation of the Rome IV Diagnostic Questionnaire for Adults
Palsson, O. S., Whitehead, W. E., van Tilburg, M. A. L., Chang, L., Chey, W., Crowell, M. D., Keefer, L., Lembo, A. J., Parkman, H. P., Rao, S. S. C., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.014 · Cited by 719 · cited 12×
“Therefore, the frequency threshold for pain in IBS was set statistically at a minimum of once a week in Rome IV.(37,39) Another example is the frequency of pain or burning above the umbilicus, a cardinal symptom for functional dyspepsia depicted in Figure 1.”
BackgroundMethodResultInfluentialFunctional Esophageal Disorders
Galmiche, J. P., Clouse, R. E., Bálint, A., Cook, I. J., Kahrilas, P. J., Paterson, W. G., & Smout, A. J. P. M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.08.060 · Cited by 602
Aziz, Q., Fass, R., Gyawali, C. P., Miwa, H., Pandolfino, J. E., & Zerbib, F. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.012 · Cited by 595
Camilleri, M., Northcutt, A. R., Kong, S., Dukes, G. E., McSorley, D., & Mangel, A. W. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02033-x · Cited by 556
Sperber, A. D., Dumitrascu, D., Fukudo, S., Gerson, C., Ghoshal, U. C., Gwee, K. A., Hungin, A. P. S., Kang, J.-Y., Minhu, C., Schmulson, M., et al. (2017) · Gut · doi:10.1136/gutjnl-2015-311240 · Cited by 554
Self-citationRao, S. S. C., Bharucha, A. E., Chiarioni, G., Felt-Bersma, R., Knowles, C., Malcolm, A., & Wald, A. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.009 · Cited by 527
Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis
Ford, A. C., Marwaha, A., Sood, R., & Moayyedi, P. (2015) · Gut · doi:10.1136/gutjnl-2014-307843 · Cited by 525 · cited 1×
“Furthermore, this higher frequency in women probably responds to an epidemiological phenomenon that explains why many functional gastrointestinal symptoms including uninvestigated dyspepsia are more frequent in women.(41,42)”
BackgroundFunctional dyspepsia : a classification with guidelines for diagnosis and management
Talley, N. (1991) · Medical Entomology and Zoology · Cited by 435
The Intestinal Microenvironment and Functional Gastrointestinal Disorders
Barbara, G., Feinle-Bisset, C., Ghoshal, U. C., Santos, J., Vanner, S. J., Vergnolle, N., Zoetendal, E. G., & Quigley, E. M. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.028 · Cited by 335 · cited 1×
“These factors can interact with the gut mucosa not only triggering a leaky barrier, but in the presence of a permeability abnormality may allow an amplification of signaling from the lumen to neural and immune pathways, generating functional gastrointestinal symptoms.(33) The “Psychosocial Aspects of Functional Gastro…”
BackgroundRao, S. S. C., Mudipalli, R. S., Stessman, M., & Zimmerman, B. (2004) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2004.00526.x · Cited by 269
Cotton, P. B., Durkalski, V., Romagnuolo, J., Pauls, Q., Fogel, E., Tarnasky, P., Aliperti, G., Freeman, M., Kozarek, R., Jamidar, P., et al. (2014) · JAMA · doi:10.1001/jama.2014.5220 · Cited by 255
Self-citationThe Narcotic Bowel Syndrome: Clinical Features, Pathophysiology, and Management
Grunkemeier, D. M. S., Cassara, J. E., Dalton, C. B., & Drossman, D. A. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.06.013 · Cited by 243 · cited 1×
“Narcotic bowel syndrome/opiate induced-gastrointestinal hyperalgesia is characterized by the paradoxical development of, or increases in, abdominal pain associated with continuous or increasing dosages of opioids.(65) NBS can occur in patients with DGBI, chronic organic gastrointestinal diseases, and painful malignant…”
BackgroundSelf-citationGallbladder and Sphincter of Oddi Disorders
Cotton, P. B., Elta, G. H., Carter, C. R., Pasricha, P. J., & Corazziari, E. S. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.033 · Cited by 234
Kellow, J., Lee, O. Y., Chang, F. Y., Thongsawat, S., Mazlam, M. Z., Yuen, H., Gwee, K. A., Bak, Y. T., Jones, J., & Wagner, A. (2003) · Gut · doi:10.1136/gut.52.5.671 · Cited by 231
Marciani, L., Cox, E. F., Hoad, C. L., Pritchard, S., Totman, J. J., Foley, S., Mistry, A., Evans, S., Gowland, P. A., & Spiller, R. C. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.10.055 · Cited by 218
Diagnostic accuracy study of anorectal manometry for diagnosis of dyssynergic defecation
Grossi, U., Carrington, E. V., Bharucha, A. E., Horrocks, E. J., Scott, S. M., & Knowles, C. H. (2016) · Gut · doi:10.1136/gutjnl-2014-308835 · Cited by 205
A prospective assessment of bowel habit in irritable bowel syndrome in women: Defining an alternator
Drossman, D. A., Morris, C. B., Hu, Y., Toner, B. B., Diamant, N., Leserman, J., Shetzline, M., Dalton, C., & Bangdiwala, S. I. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.12.006 · Cited by 203
Self-citationRatuapli, S. K., Bharucha, A. E., Noelting, J., Harvey, D. M., & Zinsmeister, A. R. (2013) · Gastroenterology · doi:10.1053/j.gastro.2012.10.049 · Cited by 189
Relationship between symptoms and ingestion of a meal in functional dyspepsia
Bisschops, R., Karamanolis, G., Arts, J., Caenepeel, P., Verbeke, K., Janssens, J., & Tack, J. (2008) · Gut · doi:10.1136/gut.2007.137125 · Cited by 188 · cited 1×
“However, pathophysiological studies investigating the effect of meal ingestion on symptom generation demonstrated that not only postprandial fullness and early satiety but also, epigastric pain or burning and nausea may increase after meal ingestion.(46) In other words, they can overlap.”
BackgroundManometry based randomised trial of endoscopic sphincterotomy for sphincter of Oddi dysfunction
Toouli, J., Roberts-Thomson, I. C., Kellow, J., Dowsett, J., Saccone, G. T. P., Evans, P., Jeans, P., Cox, M., Anderson, P., Worthley, C., et al. (2000) · Gut · doi:10.1136/gut.46.1.98 · Cited by 181
Epidemiology of irritable bowel syndrome in Asia: Something old, something new, something borrowed
Gwee, K., Lu, C., & Ghoshal, U. C. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05984.x · Cited by 170 · cited 1×
“Also considered were the explanatory models of illness that may impose a barrier to the physician-patient relationship; gender; family relationships that can have a significant effect on the illness experience of the patient; and last but not least, symptom reporting as this varies between groups.(23,30) The most char…”
BackgroundCentrally Mediated Disorders of Gastrointestinal Pain
Keefer, L., Drossman, D. A., Guthrie, E., Simrén, M., Tillisch, K., Olden, K. W., & Whorwell, P. J. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.034 · Cited by 168
Self-citationSavarino, E., Marabotto, E., Zentilin, P., Frazzoni, M., Sammito, G., Bonfanti, D., Sconfienza, L., Assandri, L., Gemignani, L., Malesci, A., et al. (2011) · Digestive and Liver Disease · doi:10.1016/j.dld.2011.01.016 · Cited by 158 · cited 1×
“However, with the addition of impedance to esophageal pH monitoring it has been shown that 38% patients did not have acid reflux (pH-), yet had a positive symptom association based on the symptom associated probability (SAP+), in other words they had esophageal hypersensitivity with only 29% having true functional hea…”
BackgroundThe functional gastrointestinal disorders: Diagnosis, pathophysiology, and treatment
Camilleri, M. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90612-6 · Cited by 155
Age, Gender, and Women’s Health and the Patient
Houghton, L. A., Heitkemper, M. M., Crowell, M. D., Emmanuel, A. V., Halpert, A. D., McRoberts, J. A., & Toner, B. B. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.017 · Cited by 132
Thompson, W. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.03.011 · Cited by 124
Rome IV Functional Gastrointestinal Disorders: for Primary Care and Non-GI Clinicians
(2016) · The Rome Foundation eBooks · doi:10.24890/pc · Cited by 116
Consensus Recommendations on Initiating Prescription Therapies for Opioid-Induced Constipation
Argoff, C. E., Brennan, M. J., Camilleri, M., Davies, A., Fudin, J., Galluzzi, K. E., Gudin, J., Lembo, A., Stanos, S. P., & Webster, L. R. (2015) · Pain Medicine · doi:10.1111/pme.12937 · Cited by 112 · cited 1×
“Recently, peripherally acting μ-opioid antagonists (PAMORAs) that block the opioid receptors in the gastrointestinal tract but not centrally, have been developed.(62)”
BackgroundMulticultural Aspects in Functional Gastrointestinal Disorders (FGIDs)
Francisconi, C. F. D. M., Sperber, A. D., Fang, X., Fukudo, S., Gerson, M., Kang, J., & Schmulson, M. J. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.013 · Cited by 105 · cited 3×
“Notwithstanding, the differences in healthcare systems can influence the diagnostic work-up and treatment itself.(27)”
BackgroundSelf-citationJamal, M. M., Adams, A. B., Jansen, J.-P., & Webster, L. R. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.106 · Cited by 103 · cited 1×
“Initial treatment of OIC is similar to that of functional constipation including laxatives and lubiprostone has been approved by FDA for patients with OIC in patients with non-cancer pain.(61) Also, opioid receptors antagonists such as naloxone and nalbuphine that are centrally active, can be used but may be related w…”
MethodOutryve, M. V., Milo, R., Toussaint, J., & Eeghem, P. V. (1991) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199102000-00012 · Cited by 95
Drossman, D. A. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.56 · Cited by 82
Self-citationMeasuring symptoms in the irritable bowel syndrome: development of a framework for clinical trials
Spiegel, B. M. R., Bolus, R., Agarwal, N., Sayuk, G., Harris, L. A., Lucak, S., Esrailian, E., Chey, W. D., Lembo, A., Karsan, H., et al. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04464.x · Cited by 80 · cited 1×
“Also, discomfort has different meanings in different languages and is an ambiguous term to patients.(51) Thus, only abdominal pain is now included.”
BackgroundLewis, M. J. V., Reilly, B., Houghton, L. A., & Whorwell, P. J. (2001) · Gut · doi:10.1136/gut.48.2.216 · Cited by 73 · cited 1×
“The addition of distension also reflects the findings with new technologies such as abdominal plethysmography.(59) Rome IV recognizes that patients may also report symptoms of mild abdominal pain and/or minor bowel movement abnormalities.”
ResultDrossman, D. A., Morris, C. B., Edwards, H., Wrennall, C. E., Weinland, S. R., Aderoju, A. O., Kulkarni-Kelapure, R. R., Hu, Y. J., Dalton, C., Bouma, M. H., et al. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.142 · Cited by 67 · cited 1×
“A detoxification protocol has been described elsewhere.(66)”
Self-citationBarau, E., & Dupont, C. (1990) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.1990.tb10062.x · Cited by 65
Gastric Emptying and Dyspeptic Symptoms in the Irritable Bowel Syndrome
Van Wijk, H. J., Smout, A. J. P. M., Akkermans, L. M. A., Roelofs, J. M. M., & Ten Thije, O. J. (1992) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529209165425 · Cited by 59
Ghoshal, U. C., Gwee, K.-A., Chen, M., Gong, X. R., Pratap, N., Hou, X., Syam, A. F., MurdaniAbdullah, Bak, Y.-T., Choi, M.-G., et al. (2015) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm14045 · Cited by 58
Sperber, A. D., Gwee, K. A., Hungin, A. P., Corazziari, E., Fukudo, S., Gerson, C., Ghoshal, U. C., Kang, J.-Y., Levy, R. L., Schmulson, M., et al. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12942 · Cited by 49
Self-citationSchmulson, M. J., Corazziari, E. S., Ghoshal, U. C., Myung, S., Gerson, C. D., Quigley, E. M. M., Gwee, K., & Sperber, A. D. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12402 · Cited by 47
Self-citationPrott, G., Shim, L., Hansen, R., Kellow, J., & Malcolm, A. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01503.x · Cited by 43
Schmulson, M., Adeyemo, M., Gutiérrez-Reyes, G., Charúa-Guindic, L., Farfán-Labonne, B., Ostrosky-Solis, F., Díaz-Anzaldúa, A., Medina, L., & Chang, L. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.58 · Cited by 42 · cited 1×
“Furthermore, this higher frequency in women probably responds to an epidemiological phenomenon that explains why many functional gastrointestinal symptoms including uninvestigated dyspepsia are more frequent in women.(41,42)”
BackgroundSelf-citationRome IV Functional Gastrointestinal Disorders of Gut-Brain Interaction
(2016) · The Rome Foundation eBooks · doi:10.24890/gb · Cited by 35
Hellström, P. M., Saito, Y. A., Bytzer, P., Tack, J., Mueller-Lissner, S., & Chang, L. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.78 · Cited by 31 · cited 1×
“In addition, in Rome III, pain or discomfort had to improve with defecation although in many patients, pain increases with defecation or it remains without changes.(52) Also, in Rome III, pain or discomfort onset had to be related with the other 2 criteria: onset associated with a changed in frequency of stools; onset…”
BackgroundPalsson, O. S., van Tilburg, M. A. L., Simrén, M., Sperber, A. D., & Whitehead, W. E. (2016) · Gastroenterology · doi:10.1016/s0016-5085(16)32513-6 · Cited by 25
Schmulson, M. J., López‐Colombo, A., Mendoza-Gomez, A., Montiel-Jarquín, Á. J., & Morgan, D. R. (2012) · Gastroenterology · doi:10.1016/s0016-5085(12)63220-x · Cited by 18
Self-citationFunctional oesophageal disorders
Sifrim, D. A., & Amarasinghe, G. (2015) · Hamdan Medical Journal · doi:10.7707/hmj.467 · Cited by 17
Rome IV Diagnostic Algorithms for Common GI Symptoms
Drossman, D. A., Chang, L., Chey, W. D., Kellow, J. E., Tack, J. F., & Whitehead, W. E. (2017) · Cited by 15
Self-citationRome IV Multidimensional Clinical Profile: for Functional Gastrointestinal Disorders
(2016) · The Rome Foundation eBooks · doi:10.24890/mdcp · Cited by 13
Morgan, D. R., Martin, C. F., Peña-Galo, E. M., Cortes, L., Domínguez, R. L., Peña, R., & Schmulson, M. J. (2012) · Gastroenterology · doi:10.1016/s0016-5085(12)62199-4 · Cited by 4
Self-citation
Research works printed but not linked: 9
- 10.1097/00005176-199007000-00015 · doi:10.1097/00005176-199007000-00015 · Paper page
- Ballard, R (2002). Race, culture and ethnicity. New developments in sociology, Holborn, M, ed. Ormskirk: The Causeway Press
- Quigley, EM, Barbara, G, Feinle-Bisset, C, and The Rome IV Committees (2016). The intestinal microenvironment an functional gastrointestinl disorders. Rome IV functional gastrointestinal disorders – disorders of gut-brain interaction, Drossman, DA, Chang, LC, Kellow, WJ, Tack, J, and Whitehead, WE, ed. Raleigh, NC: The Rome Foundation, pp. 179-247
- Levy, RL, Crowell, MD, Drossman, DA, and The Rome IV Committees (2016). Byopsychosocial aspects of functional gastrointestinl disorders: How central and environmental processes contribute to the development and expression of FGIDs. Rome IV functional gastrointestinal disorders – disorders of gut-brain interaction, Drossman, DA, Chang, LC, Kellow, WJ, Tack, J, and Whitehead, WE, ed. Raleigh, NC: The Rome Foundation, pp. 443-548
- Whorwell, PJ, Keefer, L, Drossman, DA, Guthrie, E, Simrén, M, Tillisch, K, Olden, K, and The Rome IV Committees (2016). Centrally mediated disorders of gastrointestinal pain. Rome IV functional gastrointestinal disorders – disorders of gut-brain interaction, Drossman, DA, Chang, LC, Kellow, WJ, Tack, J, and Whitehead, WE, ed. Raleigh, NC: The Rome Foundation, pp. 1059-1116
- Whitehead, EE, Palsson, OS, MALvT, , Sperber, A, BS, , Tack, J, Walker, LS, YY, , and The Rome IV Committees (2016). Development and validation of the Rome IV diagnostic questionnaires. Rome IV diagnostic questionnaires and tables for investigators and clinicians, Drossman, DA, Chang, LC, Kellow, WJ, Tack, J, and Whitehead, WE, ed. Raleigh, NC: The Rome Foundation, pp. 43-92
- Talley, NJ, Stanghellini, V, Chan, FKL, and The Rome IV Committees (2016). Gastroduodenal Disorders. Rome IV functional gastrointestinal disorders – disorders of gut-brain interaction, Drossman, DA, Chang, LC, Kellow, WJ, Tack, J, and Whitehead, WE, ed. Raleigh, NC: The Rome Foundation, pp. 903-965
- Mearin, F, Lacy, BE, Chang, L, Chey, WD, Lembo, AJ, Simrén, M, Spiller, R, and The Rome IV Committees (2016). Bowel Disorders. Rome IV functional gastrointestinal disorders – disorders of gut-brain interaction, Drossman, DA, Chang, LC, Kellow, WJ, Tack, J, and Whitehead, WE, ed. Raleigh, NC: The Rome Foundation, pp. 967-1057
- 10.1053/j.gastro.2016.02.014 · DOI · Paper page
Cited by
Chronic pain: an update on burden, best practices, and new advances
Cohen, S. P., Vase, L., & Hooten, W. M. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00393-7 · Cited by 2,614
Barberio, B., Judge, C., Savarino, E. V., & Ford, A. C. (2021) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(21)00111-4 · Cited by 422
Eijsbouts, C., Zheng, T., Kennedy, N. A., Bonfiglio, F., Anderson, C. A., Moutsianas, L., Holliday, J., Shi, J., Shringarpure, S., 23andMe Research Team, et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00950-8 · Cited by 280
Lactose Intolerance, Dairy Avoidance, and Treatment Options
Szilagyi, A., & Ishayek, N. (2018) · Nutrients · doi:10.3390/nu10121994 · Cited by 249
Serra, J., Pohl, D., Azpiroz, F., Chiarioni, G., Ducrotté, P., Gourcerol, G., Hungin, A. P. S., Layer, P., Mendive, J., Pfeifer, J., et al. (2020) · Neurogastroenterology & Motility · doi:10.1111/nmo.13762 · Cited by 244
Metadata
- Authors
- Schmulson, M. J., & Drossman, D. A.
- Affiliations
- Hospital General de México (MX)
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Schmulson, Max J
- Venue
- Journal of Neurogastroenterology and Motility
- Published
- 2017-04-30
- Volume
- 23
- Issue
- 2
- Pages
- 151-163
- ISSN
- 2093-0879 (ISSN-L)
- 2093-0887
- PMC
- PMC5383110
- OpenAlex
- W2594572760
- Cited by
- 788
- References
- 68
- Citations by year
- 2026: 57 · 2025: 88 · 2024: 108 · 2023: 104 · 2022: 100 · 2021: 120 · 2020: 80 · 2019: 74 · 2018: 46 · 2017: 9
- FWCI
- 9.65
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by-nc
- Locations
- Journal of Neurogastroenterology and Motility (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Gastroenterology › Gastroesophageal reflux and treatments
- Health Sciences › Medicine › Urology › Pelvic floor disorders treatments
- Keywords
- Rome IV criteria, functional gastrointestinal disorders, irritable bowel syndrome, functional bowel disorders, opioid-induced constipation, cannabinoid hyperemesis syndrome, reflux hypersensitivity, diagnostic algorithm, biopsychosocial model, intestinal microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.